OVERVIEW

This is a very exciting time to be involved in cancer research! The 9th iteration of the Congress brings together international experts in oncology, immunobiology, pharmacology, molecular biology, and molecular imaging to discuss preclinical, translational, and clinical advances in diagnosing, treating and preventing cancer metastasis as we enter the era of precision medicine. This meeting with all the invited presentations will form the basis of a set of review articles to be published online in Clinical and Experimental Metastasis and in print in a Special Issue:

With advancements in cancer care and patient-centered treatment planning, cancer survivors today live longer and enjoy a vastly improved quality of life than thought imaginable. We hope you will participate in 9th International Congress on Cancer Metastasis, scheduled for Spring 2023 in San Francisco, California. Venue TBD

ACCREDITATION

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through a joint providership of USF Health and the Sentinel Node Oncology Foundation.  USF Health is accredited by the ACCME to provide continuing medical education for physicians.

USF Health designates this live activity for a maximum of 16.25 AMA PRA Category 1 Credits™.  Physicians should claim only the credit commensurate with the extent of their participation in the activity.

For more information please visit the official event page.